The robust 9 per cent –plus growth in South Asia till 2010, driven largely by India, where it came down to around 7 per cent in 2011-12, had one major qualifier: it was mostly associated with a rapid rise in labour productivity rather than an expansion in employment, according to the latest report Global Employment Trends from International Labour Office. Up until the end of the millennium, that is just a...

India is coming under increasing pressure from the U.S. and the European Union for the strict patentability criteria it applies for medicines. AS was only to be expected, the two landmark decisions made by the Indian patent office in recent times concerning pharmaceutical patent cases have not gone down well with the multinational drug industry. First, there was the rejection in 2006 of the patent application by the Swiss multinational...

The media's failure to recruit Dalits is a betrayal of the constitutional guarantees of equality and fraternity. There were almost none in 1992, and there are almost none today: Dalits in the newsrooms of India's media organisations. Stories from the lives of close to 25 per cent of Indians (Scheduled Castes and Scheduled Tribes) are unlikely to be known — much less broadcast or written about. Unless, of course, the stories are...

According to the WHO, TB is the third leading cause of death for women aged 15-44 worldwide.   When did we last consider TB as one of India’s biggest health problems? To refresh memories, here are a few forgotten facts about TB in India: one of the leading causes of death in India, TB kills one person every two minutes and 750 people every day. The direct and indirect annual costs of...

The government's decision to bust the price as well as monopoly of Bayer's anti-cancer drug, through the process of compulsory licensing now opens up the field for the generic industry to follow suit and could well pave the way for the availability of cheaper drugs for lifestyle diseases.  More generic companies could invoke the compulsory licensing clause of the Indian Patents Act, following Monday's decision to allow Natco Pharma to sell...